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Abstract: Olfaction is often deregulated in Alzheimer’s disease (AD) patients, and is also impaired
in transgenic Tg2576 AD mice, which overexpress the Swedish mutated form of human amyloid
precursor protein (APP). However, little is known about the molecular mechanisms that accompany
the neurodegeneration of olfactory structures in aged Tg2576 mice. For that, we have applied
proteome- and transcriptome-wide approaches to probe molecular disturbances in the olfactory
bulb (OB) dissected from aged Tg2576 mice (18 months of age) as compared to those of age
matched wild-type (WT) littermates. Some over-represented biological functions were directly
relevant to neuronal homeostasis and processes of learning, cognition, and behavior. In addition
to the modulation of CAMP responsive element binding protein 1 (CREB1) and APP interactomes,
an imbalance in the functionality of the IκBα-NFκB p65 complex was observed during the aging
process in the OB of Tg2576 mice. At two months of age, the phosphorylated isoforms of olfactory
IκBα and NFκB p65 were inversely regulated in transgenic mice. However, both phosphorylated
proteins were increased at 6 months of age, while a specific drop in IκBα levels was detected in
18-month-old Tg2576 mice, suggesting a transient activation of NFκB in the OB of Tg2576 mice. Taken
together, our data provide a metabolic map of olfactory alterations in aged Tg2576 mice, reflecting the
progressive effect of APP overproduction and β-amyloid (Aβ) accumulation on the OB homeostasis
in aged stages.
Keywords: Tg2576 mice; olfactory bulb; proteogenomics; mass-spectrometry
Int. J. Mol. Sci. 2017, 18, 2260; doi:10.3390/ijms18112260 www.mdpi.com/journal/ijms
Int. J. Mol. Sci. 2017, 18, 2260 2 of 16
1. Introduction
Olfactory dysfunction has been related to aging and Alzheimer’s disease (AD) [1,2]. The smell
impairment is considered an early event of AD, preceding the appearance of dementia symptoms.
The Tg2576 transgenic mice express the hAPPSw via the hamster prion promoter, an isoform of
the human amyloid precursor protein (APP) with double mutation K670N, M671L [3]. These mice
displayed an increase of APP production with consequent overproduction of β-amyloid (Aβ) 40
and Aβ42 and plaques formation in the frontal, temporal, and entorhinal cortices, hippocampus,
presubiculum, and cerebellum at about 11–13 months of age [4]. There is strong evidence that
accumulation of Aβ peptide is responsible for age-related memory decline in these mice [5–7]. Other
than the increase in Aβ production, these mice can also display hyperphosphorylated tau at old age.
Synaptic deficits, and mitochondrial imbalance have been reported for this late-plaque model [8,9].
Metabolic and posttranslational modification alterations occur long before the onset of behavioral
impairment [10–12]. However, Tg2576 mice did not present a profound cognitive impairment, even at
old ages [13].
The olfactory bulb (OB) is the first brain structure of the olfactory pathway [14]. APP processing
products have been observed in the OB of 1-month-old Tg2576 mice, as has Aβ deposition at
13.5 months of age [15]. Moreover, Tg2576 mice (between ages of 6.5 and 8 months) present a reduced
rate of OB neurogenesis, a reduction in the volume of the granular cell layers of the OB [16], and some
olfactory memory deficits [16,17]. A detailed analysis of olfaction in Tg2576 mice also revealed
behavioral deficits in odor habituation and discrimination [18,19]. Interestingly, the appearance of
these behavioral impairments corresponds with a progressive Aβ deposition in specific olfactory
structures [18]. In view of these data, an in depth biochemical characterization of the OB is necessary
to reveal the missing links in the biochemical understanding of smell impairments in Tg2576 AD mice.
In this study, we used a discovery platform, applying mass-spectrometry based quantitative
proteomics and transcriptome-wide analyses, to decipher the pathophysiological mechanisms that
are disturbed in the OB from aged Tg2576 mice (18 months of age) as compared to those of age
matched background strain control mice. 107 differential genes and 25 differentially expressed proteins
were detected, pinpointing specific molecular pathways, protein interactomes, and potential olfactory
therapeutic targets.
2. Results and Discussion
OB perturbations are responsible for olfactory dysfunction in neurological syndromes [2], however,
few studies have examined this structure using high throughput molecular approaches [20–23].
Focusing on the transgenic Tg2576 mouse AD model, different proteomic and transcriptomic studies
were performed to characterize novel molecular mediators associated with AD pathophysiology in
brain structures affected during the disease progression [9,24–30]. To our knowledge, this is the
first study that characterizes olfactory-associated molecular changes in this late-plaque model using
omics technologies.
2.1. Molecular Alterations Detected in the Olfactory Bulb (OB) of 18-Month-Old Tg2576 Mice
Tg2576 transgenic mice suffer from memory deficits accompanied by β-amyloid plaques that
increase with disease progression [5–7]. We have applied a dual-omic approach to analyze the
molecular imbalance induced by the hAPPSw isoform at the olfactory level, with the final goal
to reveal novel information about the OB site-specific molecular signature at late AD stages in
18-month-old Tg2576 mice. To analyze the potential differences in olfactory molecular expression
profiles, OB specimens for each experimental group (Tg2576 and WT mice) were subjected to chemical
tags (isobaric tag for relative and absolute quantitation, iTRAQ) coupled to tandem mass spectrometry
(3 mice/condition) and into RNA microarray platform (3 mice/condition) (Figure 1).
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Figure 1. An overview of the workflow used for the molecular characterization of the olfactory bulbs 
(OBs) derived from aged Tg2576 mice. 
Among 2466 quantified proteins (Table S1), differential analysis revealed 25 de-regulated 
proteins in Tg2576 OBs with respect to wild-type (WT) OBs (11 down- and 14 up-regulated in aged 
Tg2576 mice) (Figure 2A,B and Table S2). The up-regulation of our intrinsic positive control (APP) 
was verified by Western-blotting (Figure 2A). According to the STRING Database [31], this 
subproteome is mainly involved in membrane organization (False discovery rate (FDR): 1.21 × 10−5; 
e.g., SYNE2, NOL3, AP1G1), protein transport (FDR: 0.047; e.g., RAB5B, RPL28, SRPR, RPL18, 
CHMP3, COPE), and negative regulation of neuron differentiation (FDR: 0.041; e.g., APP, APOE, 
GFAP, MT3). In the transcriptomic phase, 107 protein-coding genes were differentially regulated in 
the OB of aged Tg2576 mice (16 down- and 91 up-regulated genes with respect to WTs) (Table S3). 
Gene interactome networks suggested an alteration in the response to cyclic adenosine 
monophosphate (cAMP) (down regulation of EGR1, EGR2, NR4A1, JUNB, and FOSB genes) and in 
the olfactory transduction signaling due to the up-regulation of ADCY3, and GNAL genes, together 
with the overexpression of some olfactory receptors (OR) like OLFR553, OLFR1312, and OLFR597 
genes (dashed circles in Figure 2C). 
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Figure 1. An overview of the workflow used for the molecular characterization of the olfactory bulbs
(OBs) derived from aged Tg2576 mice.
Among 2466 quantified proteins (Table S1), differential analysis revealed 25 de-regulated proteins
in Tg2576 OBs with respect to wild-type (WT) OBs (11 down- and 14 up-regulated in aged Tg2576
mice) (Figure 2A,B and Table S2). The up-regulation of our intrinsic positive control (APP) was
verified by Western-blotting (Figure 2A). According to the STRING Database [31], this subproteome
is mainly involved in membrane organization (False discovery rate (FDR): 1.21 × 10−5; e.g., SYNE2,
NOL3, AP1G1), protein transport (FDR: 0.047; e.g., RAB5B, RPL28, SRPR, RPL18, CHMP3, COPE),
and negative regulation of neuron differentiation (FDR: 0.041; e.g., APP, APOE, GFAP, MT3). In the
transcriptomic phase, 107 protein-coding genes were differentially regulated in the OB of aged Tg2576
mice (16 down- and 91 up-regulated genes with respect to WTs) (Table S3). Gene interactome networks
suggested an alteration in the response to cyclic adenosine monophosphate (cAMP) (down regulation
of EGR1, EGR2, NR4A1, JUNB, and FOSB genes) and in the olfactory transduction signaling due to
the up-regulation of ADCY3, and GNAL genes, together with the overexpression of some olfactory
receptors (OR) like OLFR553, OLFR1312, and OLFR597 genes (dashed circles in Figure 2C).
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Figure 2. Multi-omic approach to decipher the OB site-specific molecular signature in aged Tg2576 
mice. (A) Differential molecular profiling detected by the dual-omic approach in Tg2576 OBs. The 
olfactory protein expression levels of amyloid precursor protein (APP) at late Alzheimer’s disease 
(AD) stages in 18-month-old Tg2576 mice is shown. Equal loading control and quantitation values 
have been included in Table S5; (B) Heat map representing the degree of change for the differentially 
expressed proteins (Table S2) between 18-month-old wild-type (WT) and Tg2576 mice. Red and green, 
up- and down-regulated proteins, respectively; (C) Gene interactome networks for the differentially 
expressed genes detected in aged Tg2576 mice. Network analysis was performed submitting the 
corresponding gene IDs to the STRING software (v. 10.5) (Available online: https://string-db.org/). 
Only interactions tagged as “high confidence” (>0.7) in STRING database were considered. Dashed 
circles highlight the potential alteration in the response to cyclic adenosine monophosphate (cAMP) 
and in the olfactory transduction signaling. 
Moreover, RTP2 (Receptor-transporter-protein 2) was also up-regulated in the OB of Tg2576 
mice. RTP2 promotes OR cell-surface expression and activation in response to odorant stimulation 
[32]. Based on transcriptomic information from the prefrontal cortex, it has been suggested as a cause 
of the alteration in the smell perception of AD subjects [33]. According to our data, OR gene 
dysregulation has been also demonstrated in the OB, entorhinal, and frontal cortex in human AD 
subjects [34,35]. On the other hand, there was not an evident RNA-protein correlation derived from 
the differential datasets obtained from Tg2576 OBs. This may be due to the use of different sets of 
animals for each technology platform. Moreover, other reasons may also explain the observed 
discrepancy, such as the spatial and temporal delayed synthesis between mRNA and protein [36], 
post-transcriptional events, and the different hydrophobicity and solubility of the “missing 
proteome” during the proteomic phase, hampering its characterization and quantitation by mass-
spectrometry (e.g., ORs) [37]. 
2.2. Biological Functions and Neuronal-Specific Processes Altered in the OB of Aged Tg2576 Mice 
To obtain a more detailed description of the proteogenomic modulation in the Tg2576 OBs, 
differential datasets were analyzed for higher-level organization of genes and proteins into common 
biological pathways. For that, differential proteomic and transcriptomic datasets were merged and 
functionally analyzed across specific biological functions using the Ingenuity Pathway Analysis (IPA) 
software (V. 36601845, Release Date: 22 June 2017, Ingenuity Systems®, Redwood City, CA, USA). Some 
statistically over-represented processes were directly relevant to cell movement (p-value: 0.0003), cell 
survival (p-value: 0.00015), and cell death (p-value: 1.08 × 10−6) (Figure 3A and Table S4). Moreover, 
molecular clusters involved in learning (p-value: 0.004), cognition (p-value: 0.0007), behavior (p-value: 
0.003), and dementia (p-value: 0.003) were also significantly represented (Figure 3B and Table S4). 
Figure 2. Multi-omic approach to decipher the OB site-specific molecular signature in aged Tg2576 mice.
(A) Differential molecular profiling detected by the dual-omic approach in Tg2576 OBs. The olfactory
protein expression levels of amyloid precursor protein (APP) at late Alzheimer’s disease (AD) stages
in 18-month-old Tg2576 mice is shown. Equal loading control and quantitation values have been
included in Table S5; (B) Heat map representing the degree of change for the differentially expressed
proteins (Table S2) between 18-month-old wild-type (WT) and Tg2576 mice. Red and green, up- and
down-regulated proteins, respectively; (C) Gene interactome networks for the differentially expressed
genes detected in aged Tg2576 mice. Network analysis was performed submitting the corresponding
gene IDs to the STRING software (v. 10.5) (Available online: https://string-db.org/). Only interactions
tagged as “high confidence” (>0.7) in STRING database were considered. Dashed circles highlight the
potential alteration in the response to cyclic adenosine monophosphate (cAMP) and in the olfactory
transduction signaling.
Moreover, RTP2 (Receptor-transporter-protein 2) was also up-regulated in the OB of Tg2576 mice.
RTP2 promotes OR cell-surface expression and activation in response to odorant stimulation [32].
Based on transcriptomic information from the prefrontal cortex, it has been suggested as a cause of the
alteration in the smell perception of AD subjects [33]. According to our data, OR gene dysregulation
has been also demonstrated in the OB, entorhinal, and frontal cortex in human AD subjects [34,35].
On the other hand, there was not an evident RNA-protein correlation derived from the differential
datasets obtained from Tg2576 OBs. This may be due to the use of different sets of animals for each
technology platform. Moreover, other reasons may also explain the observed discrepancy, such as the
spatial and temporal delayed synthesis between mRNA and protein [36], post-transcriptional events,
and the different hydrophobicity and solubility of the “missing proteome” during the proteomic phase,
hampering its characterization and quantitation by mass-spectrometry (e.g., ORs) [37].
2.2. Biological Functions and Neuronal-Specific Processes Altered in the OB of Aged Tg2576 Mice
To obtain a more detailed description of the proteogenomic modulation in the Tg2576 OBs,
differential datasets were analyzed for higher-level organization of genes and proteins into common
biological pathways. For that, differential proteomic and transcriptomic datasets were merged and
functionally analyzed across specific biological functions using the Ingenuity Pathway Analysis
(IPA) software (V. 36601845, Release Date: 22 June 2017, Ingenuity Systems®, Redwood City, CA,
USA). Some statistically over-represented processes were directly relevant to cell movement (p-value:
0.0003), cell survival (p-value: 0.00015), and cell death (p-value: 1.08 × 10−6) (Figure 3A and Table S4).
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Moreover, molecular clusters involved in learning (p-value: 0.004), cognition (p-value: 0.0007), behavior
(p-value: 0.003), and dementia (p-value: 0.003) were also significantly represented (Figure 3B and Table S4).
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Figure 3. Significantly represented biofunctions in the B of aged Tg2576 mice. Canonical (A) and
neuronal-specific (B) over-represented biofunctions in omic datasets derived from 18-month-old Tg2576
mice. In (A), 45 out of 54 molecules present in cell death category are related to apoptosis (See Table S4).
Although the role of β-amyloid in olfactory deficits detected in Tg2576 mice has been extensively
studied [18,19], there is no information about the survival potential of OB neurons in aged Tg2576
mice. To complement our proteogenomic workflow, survival and apoptotic pathways were monitored
to analyze the effect of the β-amyloid burden on the viability of the olfactory neurons in aged Tg2576
mice. For that, steady-state levels of survival proteins like Bcl-xL and activated forms of caspase-3,
-9, and -12 were measured in protein extracts from Tg2576 OBs at 18 months. The characterization
of pro- and anti-apoptotic factors revealed no activation of mitochondrial or endoplasmic reticulum
apoptotic routes in aged Tg2576 mice at the level of OB. Subsequent experiments were performed
to monitor specific survival pathways at the level of OB. Total and residue-specific phosphorylation
of focal adhesion kinase (FAK), protein kinase B (Akt), ERK activator kinase 1 (MEK)/extracellular
signal-regulated kinase (ERK), Phosphoinositide-dependent protein kinase 1 (PDK1), protein kinase
C (PKC), p38 mitogen-activated protein kinase (p38 MAPK), and mitogen-activated protein kinase
kinase 4 (SEK1/MKK4 )were measured in Tg2576 and WT OBs. As shown in Figure 4, no changes in
the activation state of this survival panel were observed between transgenic and WT mice at 18 months
of age, except a slight increase (non-significant) in the activation state of SEK1/MKK4 kinase (Figure 4).
However, deregulation of MAP kinases (MEK, ERK) and the PDK1/PKC axis has been observed
in human OB at advanced AD stages [22,23]. These differences may be partially explained by
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functional interactors (blue lines) are shown in both potentially deregulated networks in Tg2576 OBs 
(A and B). Continuous lines represent direct interactions, while discontinuous lines correspond to 
indirect functional interactions. Up-regulated molecules are shown in red, down-regulated molecules 
in green, and proteins proposed by the software in white. The complete legend of this type of 
interactomes may be found at http://ingenuity.force.com/ipa/articles/Feature_Description/Legend 
(accessed on 10 October 2017). 
Figure 5. Modulation of APP molecular interaction network in the OB of aged Tg2576 mice. Visual
representation of th relationships between differentially express d enes/proteins a d APP functional
interactors (blue lines) are hown in both potentially deregulat d networks in Tg2576 OBs (A and B).
Continuous lines represent direct interactions, while discontinuous lines correspond to indirect
functional interactions. Up-regulated molecules are shown in red, down-regulated molecules in green,
and proteins proposed by the software in white. The complete legend of this type of interactomes
may be found at http://ingenuity.force.com/ipa/articles/Feature_Description/Legend (accessed on
10 October 2017).
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Table 1. Potential upstream regulators of differential targets detected in our study.
Upstream Regulator Molecule Type p-Value Target Molecules in OB Omics Dataset
CREB1 transcriptionregulator 0.00000209
APOE, ARC, EGR1, EGR2, FOSB, GNAL, HLA-A, JUNB,
NR4A1, NR4A2, NR4A3, RBP4, SCD, ZDHHC23
NFKBIA transcriptionregulator 0.00916 BCL2A1, CD82, HLA-A, JUNB, MMP15, NID1, NR4A1
NFKB1 transcriptionregulator 0.0000748
APOE, APP, BCL2A1, CD82, EGR1, HLA-DMB,
NR4A1, TBX21
NFκB (complex) complex 0.00174 APOE, APP, BCL2A1, CD82, EGR1, GFAP, HLA-A,HLA-DMB, JUNB, KLF3
2.4. An Impairment in the Olfactory IκBα-NFκB p65 Complex Functionality during the Progression of
Alzheimer’s Disease (AD) in Tg2576 Mice
The nuclear factor NFκB controls the transcription of a wide variety of genes including pro-apoptotic
and pro-survival genes, proinflammatory cytokines, antioxidant enzymes, pro-oxidant enzymes,
and many others [43]. In general, the formation of a complex of NFκB dimer with a typical
member of IkB family prevents the nuclear translocation and gene activation function of NFκB [44].
The phosphorylation of serine 32 of IκBα leads to ubiquitination and proteasomal degradation of
IκBα, allowing for the phosphorylation of the NFκB p65 subunit and the enhancement of the p65
transactivation potential [44]. In our study, we monitored the functionality of the IκBα-NFκB p65
complex at three stages of AD: long before (2 months of age), immediately before (6 months), and
after (18 months) the appearance of Aβ plaques [9]. At two months of age, the phosphorylated
isoforms of IκBα and NFκB p65 were inversely regulated in Tg2576 transgenic mice (Figure 7A,B).
However, both phosphorylated proteins were increased at 6 months of age, whereas a specific drop
in IκBα levels was detected in 18-month-old Tg2576 mice (Figure 7A,B). Based on these data, it
may be hypothesized that APP overproduction induces a transient activation of NFκB in the OB of
Tg2576 mice compared to that of WT mice. It has been previously observed that there is an increased
NFκB activity in different hippocampal and cortical structures in post-mortem AD brains [45–47],
probably due to increased oxidative stress, inflammatory reactions, and toxicity of accumulated Aβ
peptides [43]. To deepen our understanding of the functional dynamics of the olfactory IκBα-NFκB
p65 complexes during the aging process, steady-state levels and phosphorylated isoforms were
independently evaluated in WT and Tg2576 mice during aging. For that, protein profiles were
quantified in a time-dependent manner. With respect to data obtained at 2 months of age, a specific
drop in NFκB p65 protein levels and a progressive decrease in the phosphorylated NFκB p65 subunit
were observed in WT mice, whereas an increase in NFκB p65 activity at 6 months was exclusively
observed in Tg2576 mice (Figure 7C). In addition, the increase in total and phosphorylated levels of IkB
α observed in 18-month-old WT mice, was blocked in aged Tg2576 mice (Figure 7C). Previous reports
have shown that NFκB inhibitors prevent Aβ-induced toxicity in vivo and in vitro AD experimental
models [48]. To our knowledge, the early impairment in NFκB functionality observed in Tg2576
mice at the level of OB, might open new avenues of targeting the NFκB signaling cascade at the
olfactory level, gaining new insight into disease pathogenesis and identifying potential disease
modifying agents. However, it is important to note that the phosphoproteome of IκBα-NFκB
complexes is highly complicated [44], and many post-translational modifications (PTMs) have been
characterized (see http://www.uniprot.org/uniprot/Q04206 (accessed on 10 October 2017), and
http://www.uniprot.org/uniprot/P25963 (accessed on 10 October 2017)), but it is still unclear how
the tangled crosstalk between all PTMs regulates the ability of NFκB proteins to induce or to repress
defined target genes. Due to the early olfactory imbalance detected in the IκBα-NFκB p65 complex
in Tg2576 mice, additional studies are necessary to decipher the effects of APP-dependent NFκB
dysregulation on the OB molecular landscape at early stages of AD pathology to understand the smell
impairment that appears during the AD progression in Tg2576 mice.
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Although the accumulation of Aβ oligomers in specific OB regions results in impaired neural
integrity in specific OB cell layers in Tg2576 mice during AD progression [49], our results indicate
that: (i) 1% of the 2.466 quantified proteins are differentially expressed; and (ii) 0.5% of the
20.900 protein-coding genes are differentially modulated in the OB of 18-month-old Tg2576 mice.
These data pointed out that AD-related effects on the OB transcriptome and proteome composition at
the bulk level are not as massive at RNA and protein levels at they are at old stages. It is important to
note that due to technical reasons, only the most abundant OB proteins corresponding to approximately
10% of the mouse proteome were explored. Consequently, alterations other than those reported in this
study might also participate in the AD neurodegeneration at the level of the OB in aged Tg2576 mice.
Despite the analysis of the OB proteogenome providing a unique window into their biochemistry and
dysfunction in aged Tg2576 mice, there are limitations of our study that warrant discussion. The OB
is composed by multiple cell types with a tangled connectivity and architecture [50]. In our case,
the information about specific-cell types from where proteins and mRNAs originated is lost due to the
processing of the bulk OB in our omic strategy. The implementation of novel approaches that allow
the exploration of olfactory cell-type specific molecular profiling would complement the output of our
nonbiased exploration of the OB transcriptome/proteome, reducing the effect of multiple neuronal
populations in the aged Tg2576 OBs.
3. Materials and Methods
3.1. Materials
The following reagents and materials were used. From Cell Signaling technology (Danvers, MA,
USA): anti-APP (ref. 2450), anti-FAK (ref. 3285), anti-phospho-FAK (Y576/577) (ref. 3281), anti-Akt
(ref. 4685), anti-phospho-Akt (S473) (ref. 4060), anti-PDK1 (ref. 3062), anti-phospho-PDK1 (S241)
(ref. 3061), anti-phospho-PKC pan (T514) (ref. 9379), anti-p38 MAPK (ref. 9212), anti-phospho-p38
MAPK (T180/Y182) (ref. 9211), anti-MEK1/2 (ref. 9126), anti-phospho-MEK1/2 (S217/221) (ref. 9154),
anti-ERK1/2 (ref. 9102), anti-phospho-ERK1/2 (T202/y204) (ref. 4370), anti-CREB (ref. 9104), anti-IκBα
(ref. 4814S), anti-phospho-IκBα (S32) (ref. 2859), anti-NFκB p65 (ref. 8242), anti-phospho-NFκB p65
(ref. 3033S), anti-SEK1 (ref. 9152), and anti-phospho-SEK1 (S257/T261) (Ref. 9156). Anti-PKC-pan was
from SigmaAldrich (St Louis, MO, USA) (ref. SAB4502356). Electrophoresis reagents were purchased
from Bio-Rad (Hercules, CA, USA) and trypsin from Promega (Madison, WI, USA).
3.2. Animals
Female Tg2576 transgenic mice were used [3]. Animals were housed 4–5 per cage with free
access to water and food, and they were maintained in a temperature-controlled environment on a
12 h light–dark cycle. The progressive development of AD signs in our colony has been previously
described [51]. Animal care procedures were conducted in accordance with the European Community
Council Directive (2010/63/EU, 22 September 2010) and approved by the local ethics committee.
Twelve aged animals (6 WT and 6 Tg2576 mice of 18 months of age), divided into two sets, were used
for proteomics and transcriptomics analysis (3 mice/group/platform).
3.3. Olfactory Proteomics
OB protein extraction, protein digestion, and peptide iTRAQ labelling was performed as
previously described [20–23]. Tryptic digests were labelled according to the manufacturer’s instructions
with one isobaric amine-reactive tag as follows: Tag113, WT-1; Tag114, WT-2; Tag115, WT-3; Tag116,
Tg2576-1; Tag117, Tg2576-2; Tag118, Tg2576-3. After 2 h incubation, the set of labelled samples were
pooled and evaporated in a vacuum centrifuge. To increase the proteome coverage, the peptide
pool was submitted to cation exchange chromatography using spin Columns (Pierce, Rockford, IL,
USA). Twelve fractions were collected (from 10 mM to 150 mM KCl), evaporated under vacuum,
and reconstituted into 10 µL of 2% acetonitrile, 0.1% formic acid, and 98% MilliQ-H2O prior to mass
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spectrometric analysis. Peptide mixtures were separated by reverse phase chromatography and
analyzed by mass-spectrometry as previously described [20–23]. The raw MS/MS spectra search
were processed using the MaxQuant software (v. 1.5.8.3) [52]. The parameters used were as follows:
initial maximum precursor (25 ppm), fragment mass deviations (40 ppm); variable modification
(methionine oxidation and N-terminal acetylation) and fixed modification (MMTS); enzyme (trypsin)
with a maximum of one missed cleavage; minimum peptide length (7 amino acids); false discovery
rate (FDR) for peptide spectrum match (PSM), and protein identification (1%). The frequently observed
laboratory contaminants were removed. Protein identification was considered valid with at least one
unique or “razor” peptide. The protein quantification was calculated using at least two razor + unique
peptides, and statistical significance was calculated by a two-way Student-t test (p < 0.05). A 1.3-fold
change cut-off was used. Proteins with iTRAQ ratios below the low range (0.77) were considered
to be down-regulated, whereas those above the high range (1.3) were considered to be upregulated.
The Perseus software (version 1.5.6.0) [53] was used for statistical analysis and data visualization.
Search results files and MS raw data were deposited to the ProteomeXchange Consortium (Available
online: http://proteomecentral.proteomexchange.org; accessed on 20 September 2017) via the PRIDE
partner repository [54] with the identifier PXD007795.
3.4. OB Transcriptomics
Maxwell® 16 simplyRNA Kit (Promega) was used to extract the OB mitochondrial RNAs (mRNAs)
from aged Tg2576 mice and WT littermates. The sense complementary DNA (cDNA) was fragmented
and biotinylated using the Affymetrix Clarion S Pico assay (902932; ThermoFisher Scientific, Waltham,
MA, USA). Affymetrix mouse Clarion S chips (ThermoFisher Scientific) were used according to the
manufacturer protocols. Hybridization, washing, staining, scanning, and data analysis [55] were
performed as previously described [34,35]. As in other transcriptomic studies performed in AD
brains [56,57], we worked with a p-value < 0.01 (without using any method for multiple testing
correction). Microarray data files were submitted to the GEO (Gene Expression Omnibus) database
and are available under accession number GSE103835.
3.5. Bioinformatics
The identification of specifically dysregulated regulatory/metabolic networks was analyzed
using QIAGEN’s Ingenuity Pathway Analysis (IPA) (Available online: www.qiagen.com/ingenuity;
accessed on 10 October 2017) and STRING software [31]. The IPA software considers signaling
pathway/biofunctions according to the calculated p-value and reports it hierarchically.
3.6. Immunoblotting Analysis
Equal amounts of OB protein (5 µg) were resolved in 4–15% TGX stain-free gels (Bio-Rad).
OB proteins derived from murine samples were electrophoretically transferred onto nitrocellulose
membranes using a Trans-blot Turbo transfer system (up to 25 V, 7 min) (Bio-Rad). Equal loading
of the gels was assessed by stain free digitalization and by Ponceau staining. Western-blotting was
performed as previously described [20–23]. After densitometric analyses (Image Lab Software Version
5.2; Bio-Rad), optical density values were expressed as arbitrary units and normalized to total stain in
each gel lane.
4. Conclusions
The largely similar OB proteogenome of aged WT and Tg2576 mice suggests that abnormal
protein-protein interactions or post-translational modifications, defective intracellular trafficking, or
misfolding of proteins could play a pivotal part in driving the neurodegeneration that occurs at the
olfactory level in aged Tg2576 mice. Moreover, omics sciences have partially revealed the potential
interactome of the hAPPSw isoform at the olfactory level as well as the disruption of the IκBα-NFκB
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p65 complex during the neurodegenerative process, providing molecular features that may be used as
novel olfactory drug target candidates to treat AD.
Supplementary Materials: Supplementary materials can be found at www.mdpi.com/1422-0067/18/11/2260/s1.
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